Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trisha Chakrabarty

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Affective Disorders|July 13, 2023
Early longitudinal changes in brain structure and cognitive functioning in remitted patients with recently diagnosed bipolar disorderJulian Macoveanu, Viktoria Damgaard, Alexander Tobias Ysbæk-Nielsen, et al.
Pharmacopsychiatry|March 2, 2021
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Psychological Medicine|October 5, 2019
Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 reportTrisha Chakrabarty, Kate L Harkness, Shane J McInerney, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 ReportKate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
Psychiatry Research|November 18, 2023
Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) reportKaterina Rnic, Joelle LeMoult, Ivan J Torres, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 11, 2024
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépressionVictor W Li, Jaspreet Sahota, Deea K Dev, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Affective Disorders|July 13, 2023
Early longitudinal changes in brain structure and cognitive functioning in remitted patients with recently diagnosed bipolar disorderJulian Macoveanu, Viktoria Damgaard, Alexander Tobias Ysbæk-Nielsen, et al.
Pharmacopsychiatry|March 2, 2021
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Psychological Medicine|October 5, 2019
Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 reportTrisha Chakrabarty, Kate L Harkness, Shane J McInerney, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 14, 2023
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 ReportKate L Harkness, Trisha Chakrabarty, Sakina J Rizvi, et al.
CNS Drugs|April 16, 2021
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.
Journal of Affective Disorders|February 19, 2026
Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 studyShiny Sachdeva, Victor W Li, Trisha Chakrabarty, et al.
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
Psychiatry Research|November 18, 2023
Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) reportKaterina Rnic, Joelle LeMoult, Ivan J Torres, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 11, 2024
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépressionVictor W Li, Jaspreet Sahota, Deea K Dev, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
Pageof 6